Medically Speaking: Melanoma

Published Online: Wednesday, September 26, 2012
Follow Pharmacy_Times:
In this podcast, Susan Kesmodel, MD, of the University of Maryland Marlene and Stewart Greenebaum Cancer Center in Baltimore, discusses diagnosis, treatment, and prevention of melanoma.
 
To listen to this podcast, click here.
Related Articles
Taking more nutritional supplements than needed may increase a patient’s risk of cancer.
The FDA today approved a second-line treatment for metastatic colorectal cancer.
The FDA has awarded Breakthrough Therapy status to crizotinib (Xalkori) for ROS1-positive non-small cell lung cancer.
The FDA has granted Orphan Drug Designation to AstraZeneca’s selumetinib.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$